← Back
$AVTX All transactions

Avalo Therapeutics, Inc.

A

$ Value

$0

Shares

29,500

Price

$0

Filed

Jun 18

Insider

Name

Heffernan Michael Thomas

Title

CIK

0001448914

Roles

Director

Transaction Details

Transaction Date

2025-06-17

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

29,500

Footnotes

The stock option vests 100% on the first anniversary of the date of grant, subject to the Eligible Director's continued service on such vesting date.

Filing Info

Accession No.

0001578563-25-000320

Form Type

4

Issuer CIK

0001534120

Heffernan Michael Thomas's History

Date Ticker Type Value
2025-07-08 ENGN A $0
2025-06-17 AVTX A $0
2025-06-11 TRVI A $0
2025-05-05 BHVN A $0

Other Insiders at AVTX (90d)

Insider Bought Sold Last
KAPLAN GILLA 2026-03-28
NEIL GARRY ARTHUR
Chief Executive Officer
2026-03-28
Lind Kevin Robert 2026-03-31
Jain Rita 2026-03-31
Chan Mitchell 2026-03-28
Sullivan Christopher Ryan
Chief Financial Officer
$271K 2026-04-02
KANTOFF AARON 2026-03-28
Doyle Mittie
Chief Medical Officer
$82K 2026-04-06
Goldman Jonathan 2026-03-28
Truex Samantha 2026-03-28